RA Capital Management - CENTESSA PHARMACEUTICALS PLC ownership

CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 41 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q3 2021. The put-call ratio across all filers is - and the average weighting 2.4%.

Quarter-by-quarter ownership
RA Capital Management ownership history of CENTESSA PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2022$32,087,000
-20.3%
3,577,0940.0%0.70%
-1.4%
Q4 2021$40,278,000
-32.6%
3,577,0940.0%0.71%
-14.3%
Q3 2021$59,737,000
+110.1%
3,577,094
+179.4%
0.83%
+81.6%
Q2 2021$28,435,0001,280,3000.46%
Other shareholders
CENTESSA PHARMACEUTICALS PLC shareholders Q3 2021
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 17,923,892$299,329,00065.12%
Vida Ventures Advisors, LLC 3,931,818$65,661,00018.81%
Samsara BioCapital, LLC 1,537,533$25,677,0004.03%
VR Adviser, LLC 1,127,272$18,825,0002.42%
Logos Global Management LP 1,069,545$17,861,0001.29%
Cormorant Asset Management, LP 1,727,273$28,724,0001.17%
GENERAL ATLANTIC, L.P. 9,681,818$161,686,0000.95%
Affinity Asset Advisors, LLC 203,183$3,393,0000.86%
RA Capital Management 3,577,094$59,737,0000.83%
Boxer Capital, LLC 1,334,227$22,282,0000.78%
View complete list of CENTESSA PHARMACEUTICALS PLC shareholders